Arterial thrombosis in refractory multiple myeloma patient treated with thalidomide and dexamethasone: A case report

被引：0
|
作者：
Soysal, Dilek [1 ,3 ]
Küçükşahin, Orhan [1 ]
Inci, Ayça [1 ]
Pehlivan, Mustafa [2 ]
机构：
[1] Clinics of 1st Internal Medicine, Atatürk Research Hospital, Izmir, Turkey
[2] Hematology, Atatürk Research Hospital, Izmir, Turkey
[3] Atatürk Research Hospital, First Department of Internal Medicine, Manolya Sokak, No: 44/4, Balçova, Izmir, Turkey
来源：
Turkish Journal of Medical Sciences | 2006年 / 36卷 / 04期
关键词：
9;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：247 / 250
相关论文
共 50 条
  • [1] Thalidomide and dexamethasone combination for refractory multiple myeloma
    Dimopoulos, MA
    Zervas, K
    Kouvatseas, G
    Galani, E
    Grigoraki, V
    Kiamouris, C
    Vervessou, E
    Samantas, E
    Papadimitriou, C
    Economou, O
    Gika, D
    Panayiotidis, P
    Christakis, I
    Anagnostopoulos, N
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 991 - 995
  • [2] Stroke in a multiple myeloma patient treated with thalidomide, dexamethasone and darbepoitin alpha
    Zenut, M.
    Calvet, L.
    Favier, E.
    Trechot, I.
    Faoro, A.
    Fialip, J.
    Philippe, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 81 - 81
  • [3] Completely reversible agranulocytosis in a multiple myeloma patient treated with thalidomide–dexamethasone
    Francesca Magalini
    Adriano Stella
    Paolo Sansoni
    Internal and Emergency Medicine, 2008, 3 : 383 - 385
  • [4] Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma
    Alexanian, R
    Weber, D
    Anagnostopoulos, A
    Delasalle, K
    Wang, M
    Rankin, K
    SEMINARS IN HEMATOLOGY, 2003, 40 (04) : 3 - 7
  • [5] Thalidomide and dexamethasone combination for refractory multiple myeloma.
    Galani, E
    Grigoraki, V
    Kiamouris, C
    Samantas, E
    Economou, O
    Papdimitriou, C
    Gika, D
    Anagnostopoulos, N
    Dimopoulos, M
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
  • [6] Role of thalidomide with or without dexamethasone for refractory multiple myeloma
    Boulin, M
    Blanchet, F
    Isambert, N
    Solary, E
    Solier, S
    Collin, B
    Pernot, C
    Durnet-Archeray, MJ
    THERAPIE, 2002, 57 (06): : 524 - 529
  • [7] Completely reversible agranulocytosis in a multiple myeloma patient treated with thalidomide-dexamethasone
    Magalini, Francesca
    Stella, Adriano
    Sansoni, Paolo
    INTERNAL AND EMERGENCY MEDICINE, 2008, 3 (04) : 383 - 385
  • [8] Oral melphalan, dexamethasone, and thalidomide for the treatment of refractory multiple myeloma
    Asoua, Norio
    Izuno, Yoshiharu
    Okubo, Toshiya
    Ide, Kazuhiko
    Ueno, Hiroshi
    Kawakita, Makoto
    Hiroaki, Mitsuya
    Hata, Hiroyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (01) : 69 - 71
  • [9] Oral Melphalan, Dexamethasone, and Thalidomide for the Treatment of Refractory Multiple Myeloma
    Norio Asou
    Yoshiharu Izuno
    Toshiya Okubo
    Kazuhiko Ide
    Hiroshi Ueno
    Makoto Kawakita
    Hiroaki Mitsuya
    Hiroyuki Hata
    International Journal of Hematology, 2007, 86 : 69 - 71
  • [10] A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide
    Vetrichevvel, Thirthar Palanivelu
    Pise, Gajanan A.
    Thappa, Devinder Mohan
    LEPROSY REVIEW, 2008, 79 (02) : 193 - 195
12345